Twist Bioscience Corporation (NASDAQ: TWST) reported Q1 EPS of ($0.91), $0.15 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $42 million versus the consensus estimate of $38.33 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2022 revenue of $189-198 million, versus the consensus of $187.4 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.